Event Videos

Protalix reports success in oral Gaucher treatment study Gali Weinreb
 
Protalix will now have to demonstrate that the enzyme can reach the bloodstream in controllable dosages, and influence the condition of a Gaucher disease patient.
 
Protalix Biotherapeutics Inc. today reported success in a Phase I clinical trial of its oral treatment of Gaucher's disease. The study found that oral glucocerebrosidase (GCD) was well-tolerated, and active enzyme was detected in patients' blood circulation.

Janice Raquela Mendonca, 24, from Mumbai, India, is suffering from a rare and painful disease called Wilson's disease (WD) also known as hepatolenticular degeneration. Wilson's disease is caused by copper accumulation in the tissues. It is a rare genetic disease, 1 out of 40,000 people get diagnosed by this disorder.
 
Mendonca was diagnosed with the disease in April 2008.  Her symptoms were dazed vision, stiff fingers and drooling. She lost her sense of balance and showed erratic behavior.

What is Biliary Atresia (BA)?

Bile is a digestive juice secreted from the liver. Bile passes into the intestine through a tube like structure which is called bile duct. Bile juice is important for the digestion of fat in food and for absorption of fat soluble vitamins. Poor development of the bile duct is called Biliary Atresia. This can lead to cholestatic (direct) jaundice or liver damage.

How common is Biliary Atresia?

Biliary Atresia occurs in 1 in 10,000 to 20,000 live births. It is one of the commonest causes of neonatal jaundice.

Wilson's Disease is a rare genetic disease linked with copper depositing in the tissues and cells of the diagnosed. This disease turns untreatable in the later stages, but it is curable if it is detected early.
 
Dr. Aabha Nagral, presently treating around hundreds of patients suffering from Wilson's disease, defined WD. as an unexplainable chronic disease, which needs to be monitored well by experts.
This disease can be identified easily in patients.
 

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: